Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of “Buy” by Brokerages

Shares of Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) have been given an average recommendation of “Buy” by the ten analysts that are presently covering the stock, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The […]

Leave a Reply

Your email address will not be published.

Previous post Deutsche Bank Aktiengesellschaft Begins Coverage on Autolus Therapeutics (NASDAQ:AUTL)
Next post Brokerages Set Camtek Ltd. (NASDAQ:CAMT) Target Price at $58.43